- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Muscle Invasive Bladder Neoplasms in New Zealand
Total 3091 results
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Boehringer IngelheimCompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Stage III Non-small Cell Lung CancerUnited States
-
PfizerCompletedNon-Small-Cell Lung CarcinomaUnited States
-
New Mexico Cancer Care AllianceUniversity of New Mexico Cancer Center; Lovelace Respiratory Research InstituteTerminatedNon-small Cell Lung CancerUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
New Mexico Cancer Care AllianceNovartis; Fred Hutchinson Cancer CenterCompletedNon-small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedUnresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)United States
-
Merck Sharp & Dohme LLCModernaTX, Inc.RecruitingNon-small Cell Lung CancerUnited States, New Zealand, Australia, Costa Rica, Taiwan, Argentina, France, Chile, Hungary, Spain, Greece, Poland, Canada, Lithuania, Norway
-
Merck Sharp & Dohme LLCAstellas Pharma Inc; Seagen Inc.Active, not recruitingBladder CancerHungary, United States, China, Argentina, Australia, Bulgaria, Canada, Colombia, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Malaysia, Philippines, Poland, Portugal, Romania, Russian Federation, Singapo... and more
-
SCRI Development Innovations, LLCAmgenCompletedNon-Small-Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedBladder Cancer | Metastatic Transitional Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMelanoma | Sarcoma | Cervical Cancer | Breast Cancer | Pancreatic Cancer | Lung Cancer | Rectal Cancer | Prostate Cancer | Bladder Cancer | Colon Cancer | Brain Metastasis | Testicular Cancer | HEENT CancerUnited States
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Non-squamous Non-small-cell Lung Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | KEAP1 Gene Mutation | NRF2 Gene Mutation | NFE2L2 Gene MutationUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); NovartisTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | B-cell Non-Hodgkin's LymphomaUnited States
-
Eastern Cooperative Oncology GroupRecruitingMelanoma | Breast Cancer, NOS | CNS Primary Tumor, NOS | Cervical Cancer, NOS | Colorectal Cancer, NOS | Leukemia, NOS | Lymphoma, NOS | Miscellaneous Neoplasm, NOS | Non-Rhabdomyosarcoma Soft Tissue Sarcoma, NOS | Testicular Nonseminomatous Germ Cell Tumor, NOS | Thyroid Cancer, NOS | Bone Cancer, NOSUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Montefiore Medical CenterBristol-Myers SquibbRecruitingResectable Stage IIA to IIIB Non-small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.CompletedSarcoma | Leiomyosarcoma | Angiosarcoma | Histiocytoma | Malignant FibrousUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); American College of RadiologyCompleted
-
University Hospital of CologneRadboud University Medical CenterCompletedInvasive AspergillosisGermany, Netherlands
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; University of Washington; H. Lee...Active, not recruiting
-
Eli Lilly and CompanyMerck Sharp & Dohme LLC; Loxo Oncology, Inc.RecruitingUrinary Bladder Neoplasms | Neoplasm Metastasis | Ureteral NeoplasmsUnited States, Korea, Republic of, Spain, United Kingdom, Germany, Japan, France, China, Australia, Netherlands, Canada, Israel, Norway, Italy
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Active, not recruitingNon-Small-Cell-Lung Cancer (NSCLC)United States
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Breast Cancer | Invasive Carcinoma of the Breast | Node Negative Breast Cancer | Micrometastasis Breast CancerUnited States
-
Proacta, IncorporatedTerminatedNon-Small Cell Lung CancerUnited States, Canada, New Zealand
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)Terminated
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Invasive Breast Cancer | Lobular CarcinomaUnited States
-
NYU Langone HealthRecruiting
-
Genentech, Inc.Chugai Pharmaceutical Co.RecruitingGastric Cancer | Metastatic Solid Tumor | Non-small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaKorea, Republic of, Spain, Japan, New Zealand, Australia, United States, Italy, Brazil
-
Daiichi Sankyo, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)Taiwan
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkUnknown
-
PRAECIS Pharmaceuticals Inc.TerminatedSolid Tumors | Non-Hodgkin's Lymphoma,United States
-
Hellenic Cooperative Oncology GroupStavros Niarchos Foundation; Care Across LtdRecruitingNon-Small Cell Carcinoma of Lung, TNM Stage 4Greece
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
University of Michigan Rogel Cancer CenterTerminated
-
Greg Durm, MDAstraZeneca; Indiana University School of MedicineTerminatedNon Small Cell Lung Cancer | Stage III Non-small-cell Lung CancerUnited States
-
AmgenUnknownBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Columbia UniversityNational Cancer Institute (NCI)TerminatedEsophageal Cancer | Non-small Cell Lung CancerUnited States
-
BiogenTerminatedLymphoma, Non-Hodgkin'sUnited States
-
National Cancer Institute (NCI)CompletedLung Adenocarcinoma | Minimally Invasive Lung Adenocarcinoma | Malignant Pleural Effusion | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Malignant Pericardial Effusion | Lung Adenosquamous CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma | Refractory Primary Central Nervous System Neoplasm | Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma and other conditionsUnited States, Puerto Rico
-
Weill Medical College of Cornell UniversityOSI PharmaceuticalsCompletedCarcinoma, Non-small Cell LungUnited States
-
Hoffmann-La RocheTerminatedNon-Hodgkin's LymphomaUnited States, Australia, Korea, Republic of, Germany, New Zealand
-
National Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Leptomeningeal Neoplasm | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Icahn School of Medicine at Mount SinaiRecruitingNon-Small Cell Lung CancerUnited States
-
Incyte CorporationHoffmann-La Roche; Genentech, Inc.TerminatedUC (Urothelial Cancer) | NSCLC (Non-small Cell Lung Carcinoma)United States
-
AbbVieGenentech, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung Cancer and MET Exon 14 Skipping MutationUnited States